Skip to main content
Top
Published in: Perioperative Medicine 1/2018

Open Access 01-12-2018 | Research

Relationship between endotoxin core, staphylococcal and varicella antibody levels and outcome following aortic valve replacement surgery: a prospective observational study

Authors: Andrew Smith, Sarka Moravcova, Thomas A. Treibel, Patricia Colque-Navarro, Roland Mollby, James C. Moon, Colin Hamilton-Davies

Published in: Perioperative Medicine | Issue 1/2018

Login to get access

Abstract

Background

Morbidity and mortality following cardiac valve surgery is high. Immunity is an important contributor to outcome. This study examines the relationship of staphylococcal and endotoxin antibody levels to outcome following cardiac surgery.

Methods

Using enzyme-linked immunosorbent assays (ELISA), we measured pre-operative levels of antibodies to endotoxin core (EndoCAb); 3 common staphylococcal epitopes and varicella on saved serum of 60 adult patients scheduled to undergo elective primary surgical aortic valve replacement (AVR). Primary outcome measure was post-operative length of stay (LOS) in hospital with secondary outcomes being development of infective complications, length of stay on the intensive care unit (ICU) and 30-day mortality. Patients were quartiled according to antibody levels and outcomes compared between the quartile groups using Mann-Whitney tests for length of stay and Fisher’s test for development of infection.

Results

Sixty patients (34 M, 26 F) were recruited with mean age 73 years (IQR 66–78), mean body mass index (BMI) 27.7 (IQR 25–31) and EuroSCORE II 1.44 (0.95–1.99). Those patients in the lower quartile for pre-operative antibody level had a longer post-operative stay than the upper quartile. EndoCAb (median IgG level Q1 42.2 MU/ml vs Q4 256 MU/ml) 9 vs 6 days, p = 0.025; alpha-toxin (median IgG level Q1 63 U vs Q4 558 U) 10 vs 7 days, p = 0.034; teichoic acid (median IgG level Q1 14 U vs Q4 419 U) 10 vs 8 days, p = 0.441; staphylococcal enterotoxin A (median IgG level Q1 55 U vs Q4 427 U) 9 vs 7 days, p = 0.865; varicella zoster (median IgG level Q1 1.325 U vs Q4 2.54 U) 8 vs 7 days, p = 1.0; and combined antibody levels 10 vs 6 days, p = 0.017. There were no differences in the number developing post-operative infections for each antibody type. The combined antibody analysis suggested a reduction in proportion of individuals developing infection from the upper vs lower quartile: 0 vs 0.33, p = 0.042.

Conclusions

This study again suggests the inverse relationship between endotoxin core antibody levels and outcome following aortic valve surgery as well as suggesting a similar relationship with antibodies to staphylococcus. There is no such relationship for antibody levels against an organism not providing a peri-operative threat. Understanding this relationship may enable therapeutic manipulation of immune status, re-evaluation of risk and further investigation of the low immune state.

Trial registration

The patients in this study are a sub-group of the RELIEF AS study.
ClinicalTrials.gov identifier NCT02174471.
Literature
go back to reference Allen KB, Fowler VG Jr, Gammie JS, et al. Staphylococcus aureus infections after elective cardiothoracic surgery: observations from an international randomized placebo-controlled trial of an investigational s aureus vaccine. Open Forum Infect Dis. 2014;1:ofu071.CrossRefPubMedPubMedCentral Allen KB, Fowler VG Jr, Gammie JS, et al. Staphylococcus aureus infections after elective cardiothoracic surgery: observations from an international randomized placebo-controlled trial of an investigational s aureus vaccine. Open Forum Infect Dis. 2014;1:ofu071.CrossRefPubMedPubMedCentral
go back to reference Andersen LW, Baek L, Degn H, Lehd J, Krasnik M, Rasmussen JP. Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg. 1987;93:115–9.PubMed Andersen LW, Baek L, Degn H, Lehd J, Krasnik M, Rasmussen JP. Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg. 1987;93:115–9.PubMed
go back to reference Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, et al. Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA. 1997;277:646–50.CrossRefPubMed Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, et al. Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA. 1997;277:646–50.CrossRefPubMed
go back to reference Bennett-Guerrero E, Panah MH, Barclay GR, et al. Decreased endotoxin immunity is associated with greater mortality and/or prolonged hospitalization after surgery. Anesthesiology. 2001;94:992–8.CrossRefPubMed Bennett-Guerrero E, Panah MH, Barclay GR, et al. Decreased endotoxin immunity is associated with greater mortality and/or prolonged hospitalization after surgery. Anesthesiology. 2001;94:992–8.CrossRefPubMed
go back to reference Bone RC, Balk RA, Fein AM, et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 sepsis study group. Crit Care Med. 1995;23:994–1006.CrossRefPubMed Bone RC, Balk RA, Fein AM, et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 sepsis study group. Crit Care Med. 1995;23:994–1006.CrossRefPubMed
go back to reference Brown PP, Kugelmass AD, Cohen DJ, et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg. 2008;85:1980–6.CrossRefPubMed Brown PP, Kugelmass AD, Cohen DJ, et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg. 2008;85:1980–6.CrossRefPubMed
go back to reference Soderquist B, Colque-Navarro P, Blomqvist L, Olcen P, Holmberg H, Mollby R. Enzyme immunoassay for detection of ∝-toxin from staphylococcus aureus. Serodiagn Immunother Infect Dis. 1993;5(1):23–6.CrossRef Soderquist B, Colque-Navarro P, Blomqvist L, Olcen P, Holmberg H, Mollby R. Enzyme immunoassay for detection of ∝-toxin from staphylococcus aureus. Serodiagn Immunother Infect Dis. 1993;5(1):23–6.CrossRef
go back to reference Colque-Navarro P, Jacobsson G, Andersson R, Flock JI, Mollby R. Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clin Vacc Immunol. 2010;17:1117–23.CrossRef Colque-Navarro P, Jacobsson G, Andersson R, Flock JI, Mollby R. Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clin Vacc Immunol. 2010;17:1117–23.CrossRef
go back to reference Colque-Navarro P, Palma M, Soderquist B, Flock JI, Mollby R. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol. 2000;7:14–20.PubMedPubMedCentral Colque-Navarro P, Palma M, Soderquist B, Flock JI, Mollby R. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol. 2000;7:14–20.PubMedPubMedCentral
go back to reference Colque-Navarro P, Soderquist B, Holmberg H, Blomqvist L, Olcen P, Mollby R. Antibody response in Staphylococcus aureus septicaemia––a prospective study. J Med Microbiol. 1998;47:217–25.CrossRefPubMed Colque-Navarro P, Soderquist B, Holmberg H, Blomqvist L, Olcen P, Mollby R. Antibody response in Staphylococcus aureus septicaemia––a prospective study. J Med Microbiol. 1998;47:217–25.CrossRefPubMed
go back to reference Coskun D, Aytac J, Aydinli A, Bayer A. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect. 2005;60:176–9.CrossRefPubMed Coskun D, Aytac J, Aydinli A, Bayer A. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect. 2005;60:176–9.CrossRefPubMed
go back to reference Fowler VG Jr, O’Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation. 2005;112:I358–65.CrossRefPubMed Fowler VG Jr, O’Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation. 2005;112:I358–65.CrossRefPubMed
go back to reference Garey KW, Kumar N, Dao T, Tam VH, Gentry LO. Risk factors for postoperative chest wound infections due to gram-negative bacteria in cardiac surgery patients. J Chemother. 2006;18:402–8.CrossRefPubMed Garey KW, Kumar N, Dao T, Tam VH, Gentry LO. Risk factors for postoperative chest wound infections due to gram-negative bacteria in cardiac surgery patients. J Chemother. 2006;18:402–8.CrossRefPubMed
go back to reference Granstrom M, Julander I, Mollby R. Serological diagnosis of deep Staphylococcus aureus infections by enzyme-linked immunosorbent assay (ELISA) for staphylococcal hemolysins and teichoic acid. Scand J Infect Dis Supp. 1983a;41:132–9. Granstrom M, Julander I, Mollby R. Serological diagnosis of deep Staphylococcus aureus infections by enzyme-linked immunosorbent assay (ELISA) for staphylococcal hemolysins and teichoic acid. Scand J Infect Dis Supp. 1983a;41:132–9.
go back to reference Granstrom M, Julander IG, Hedstrom SA, Mollby R. Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections. J Clin Microbiol. 1983b;17:640–6.PubMedPubMedCentral Granstrom M, Julander IG, Hedstrom SA, Mollby R. Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections. J Clin Microbiol. 1983b;17:640–6.PubMedPubMedCentral
go back to reference Hamilton-Davies C. The role of pre-operative endotoxin core antibody (EndoCAb) status in outcome following cardiac surgery and approaches to elevating EndoCAb. London: University of London; 1998. Hamilton-Davies C. The role of pre-operative endotoxin core antibody (EndoCAb) status in outcome following cardiac surgery and approaches to elevating EndoCAb. London: University of London; 1998.
go back to reference Hamilton-Davies C, Barclay GR, Cardigan RA, et al. Relationship between preoperative endotoxin immune status, gut perfusion, and outcome from cardiac valve replacement surgery. Chest. 1997;112:1189–96.CrossRefPubMed Hamilton-Davies C, Barclay GR, Cardigan RA, et al. Relationship between preoperative endotoxin immune status, gut perfusion, and outcome from cardiac valve replacement surgery. Chest. 1997;112:1189–96.CrossRefPubMed
go back to reference Hamilton-Davies C, Barclay GR, Murphy WG, Machin SJ, Webb AR. Passive immunisation with IgG endotoxin core antibody hyperimmune fresh frozen plasma. Vox Sang. 1996;71:165–9.CrossRefPubMed Hamilton-Davies C, Barclay GR, Murphy WG, Machin SJ, Webb AR. Passive immunisation with IgG endotoxin core antibody hyperimmune fresh frozen plasma. Vox Sang. 1996;71:165–9.CrossRefPubMed
go back to reference Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.CrossRefPubMed Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.CrossRefPubMed
go back to reference Hortal J, Giannella M, Perez MJ, et al. Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med. 2009;35:1518–25.CrossRefPubMed Hortal J, Giannella M, Perez MJ, et al. Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med. 2009;35:1518–25.CrossRefPubMed
go back to reference Kanafani ZA, Arduino JM, Muhlbaier LH, et al. Incidence of and preoperative risk factors for Staphylococcus aureus bacteremia and chest wound infection after cardiac surgery. Infect Control Hosp Epidemiol. 2009;30:242–8.CrossRefPubMed Kanafani ZA, Arduino JM, Muhlbaier LH, et al. Incidence of and preoperative risk factors for Staphylococcus aureus bacteremia and chest wound infection after cardiac surgery. Infect Control Hosp Epidemiol. 2009;30:242–8.CrossRefPubMed
go back to reference Kanclerski K, Soderquist B, Kjellgren M, Holmberg H, Mollby R. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia. J Med Microbiol. 1996;44:171–7.CrossRefPubMed Kanclerski K, Soderquist B, Kjellgren M, Holmberg H, Mollby R. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia. J Med Microbiol. 1996;44:171–7.CrossRefPubMed
go back to reference Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997;112:666–75.CrossRefPubMed Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997;112:666–75.CrossRefPubMed
go back to reference Kvidal P, Bergstrom R, Malm T, Stahle E. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J. 2000;21:1099–111.CrossRefPubMed Kvidal P, Bergstrom R, Malm T, Stahle E. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J. 2000;21:1099–111.CrossRefPubMed
go back to reference Kwak YK, Vikstrom E, Magnusson KE, Vecsey-Semjen B, Colque-Navarro P, Mollby R. The Staphylococcus aureus alpha-toxin perturbs the barrier function in Caco-2 epithelial cell monolayers by altering junctional integrity. Infect Immun. 2012;80:1670–80.CrossRefPubMedPubMedCentral Kwak YK, Vikstrom E, Magnusson KE, Vecsey-Semjen B, Colque-Navarro P, Mollby R. The Staphylococcus aureus alpha-toxin perturbs the barrier function in Caco-2 epithelial cell monolayers by altering junctional integrity. Infect Immun. 2012;80:1670–80.CrossRefPubMedPubMedCentral
go back to reference McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS trial study group. Ann Int Med. 1994;121:1–5.CrossRefPubMed McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS trial study group. Ann Int Med. 1994;121:1–5.CrossRefPubMed
go back to reference Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130–8.CrossRefPubMed Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130–8.CrossRefPubMed
go back to reference Moravcova S, Kyle B, Shanahan H, Giannaris S, Smith A, Hamilton-Davies C. Variability of anti-staphylococcal antibodies in healthy volunteers and pre-cardiac surgery patients. J Periop Med. 2016;5:13.CrossRef Moravcova S, Kyle B, Shanahan H, Giannaris S, Smith A, Hamilton-Davies C. Variability of anti-staphylococcal antibodies in healthy volunteers and pre-cardiac surgery patients. J Periop Med. 2016;5:13.CrossRef
go back to reference Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.CrossRefPubMed Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.CrossRefPubMed
go back to reference Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–44. discussion 44-5CrossRefPubMed Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–44. discussion 44-5CrossRefPubMed
go back to reference Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989;79:I3–12.PubMed Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989;79:I3–12.PubMed
go back to reference Pena OM, Hancock DG, Lyle NH, et al. An endotoxin tolerance signature predicts sepsis and organ dysfunction at initial clinical presentation. EBioMedicine. 2014;1:64–71.CrossRefPubMedPubMedCentral Pena OM, Hancock DG, Lyle NH, et al. An endotoxin tolerance signature predicts sepsis and organ dysfunction at initial clinical presentation. EBioMedicine. 2014;1:64–71.CrossRefPubMedPubMedCentral
go back to reference Reizenstein E, Hallander HO, Blackwelder WC, Kuhn I, Ljungman M, Mollby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods. 1995;183:279–90.CrossRefPubMed Reizenstein E, Hallander HO, Blackwelder WC, Kuhn I, Ljungman M, Mollby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods. 1995;183:279–90.CrossRefPubMed
go back to reference Sanders J, Keogh BE, Van der Meulen J, et al. The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery. J Clin Epidemiol. 2012;65:423–33.CrossRefPubMed Sanders J, Keogh BE, Van der Meulen J, et al. The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery. J Clin Epidemiol. 2012;65:423–33.CrossRefPubMed
go back to reference Soderquist B. Surgical site infections in cardiac surgery: microbiology. APMIS. 2007;115:1008–11.CrossRefPubMed Soderquist B. Surgical site infections in cardiac surgery: microbiology. APMIS. 2007;115:1008–11.CrossRefPubMed
go back to reference Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg. 1996;20:411–7.CrossRefPubMed Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg. 1996;20:411–7.CrossRefPubMed
go back to reference van Vught LA, Klein Klouwenberg PM, Spitoni C, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315:1469–79.CrossRefPubMed van Vught LA, Klein Klouwenberg PM, Spitoni C, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315:1469–79.CrossRefPubMed
go back to reference Wang L, Han QQ, Qiao F, et al. Performance of EuroSCORE II in patients who have undergone heart valve surgery: a multicentre study in a Chinese population. Eur J Cardiothorac Surg. 2014;45:359–64.CrossRefPubMed Wang L, Han QQ, Qiao F, et al. Performance of EuroSCORE II in patients who have undergone heart valve surgery: a multicentre study in a Chinese population. Eur J Cardiothorac Surg. 2014;45:359–64.CrossRefPubMed
Metadata
Title
Relationship between endotoxin core, staphylococcal and varicella antibody levels and outcome following aortic valve replacement surgery: a prospective observational study
Authors
Andrew Smith
Sarka Moravcova
Thomas A. Treibel
Patricia Colque-Navarro
Roland Mollby
James C. Moon
Colin Hamilton-Davies
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Perioperative Medicine / Issue 1/2018
Electronic ISSN: 2047-0525
DOI
https://doi.org/10.1186/s13741-018-0101-z

Other articles of this Issue 1/2018

Perioperative Medicine 1/2018 Go to the issue